11th ESO Colorectal Cancer Observatory: innovation and care in the next 12 months
Not eligible for ESCO credits
25.06.2014
Barcelona, Spain
MASTERCLASS
Description
Chair: M. Dicato, LU
Co-chair: J. Gore-Booth, UK
A satellite symposium |  |
The European School of Oncology is pleased to announce the 11th edition of "The ESO Colorectal Cancer Observatory: innovation and care in the next 12 months", which will be held during the 16th World Congress on Gastrointestinal Cancer on June 25-28 in Barcelona, chaired by Prof. Dicato. The scope of the session is to provide the participants with a take home message on what they can expect to happen in the colorectal cancer field in the next 12 months.
In collaboration with: |
 |
General information
ESO SECRETARIAT
Daniela Mengato
European School of Oncology
Via Turati 29
20121, Milan, Italy
dmengato@eso.net
VENUE
Centre de Convencions Internacional de Barcelona (CCIB)
Rambla de Prim 1-17
08019 Barcelona
Spain
19:00 - 20:30
Room 116, Level 1
ATTENDANCE
Attendance is granted to all participants registered to the ESMO 16th World Congress on Gastrointestinal Cancer.
CONCLUSION
The conclusion of the Observatory will be made available on the ESO website.
.
Daniela Mengato
European School of Oncology
Via Turati 29
20121, Milan, Italy
dmengato@eso.net
VENUE
Centre de Convencions Internacional de Barcelona (CCIB)
Rambla de Prim 1-17
08019 Barcelona
Spain
19:00 - 20:30
Room 116, Level 1
ATTENDANCE
Attendance is granted to all participants registered to the ESMO 16th World Congress on Gastrointestinal Cancer.
CONCLUSION
The conclusion of the Observatory will be made available on the ESO website.
.
Faculty list
FACULTY
M. Dicato, Centre Hospitalier de Luxembourg, LU
F. Leung, David Geffen School of Medicine, Los Angeles, US
J. Gore-Booth, EuropaColon, London, UK
R. Labianca, Ospedali Riuniti di Bergamo, IT
B. Nordlinger, Hopital Ambroise Paré, Boulogne-Billancourt, FR
J. Pon, EuropaColon Patient Ambassador, Amsterdam, NL
J. Tabernero, Hospital Vall D'Hebron, Barcelona, ES
Programme
TOPICS
Screening on colorectal cancer
F. Leung, US
Targeted therapy
J. Tabernero, ES
Adjuvant and metastatic disease
R. Labianca, IT
Advances in surgical oncology of colorectal cancer
B. Nordlinger, FR
Survival improval in CRC over the past 20 years. Can we project into the near future?
M. Dicato, LU
The patient’s perspective
J. Pon, NL
.